Product Code: ETC6188633 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Poliomyelitis, although largely eradicated in many parts of the world due to successful vaccination programs, remains a health concern in certain regions. In Australia, the poliomyelitis market is relatively niche but is maintained by the ongoing efforts to ensure immunization and public health awareness. Australias robust healthcare infrastructure and its commitment to vaccination programs contribute to the low incidence of the disease. The government continues to support poliomyelitis eradication efforts globally through participation in the Global Polio Eradication Initiative (GPEI), ensuring that Australia remains free from polio outbreaks.
The Australia poliomyelitis market continues to be shaped by advancements in vaccination and global efforts towards eradication. Australia has seen a steady decline in polio cases due to the widespread use of the polio vaccine, and there is a strong trend towards ensuring complete eradication through immunization programs. As part of this global initiative, Australia continues to monitor for any potential outbreaks, and policies around immunization remain robust. The trend is also toward increasing public awareness of the importance of vaccination, ensuring that even remote populations are included in immunization programs.
In Australia, the poliomyelitis market faces challenges due to the country`s high immunization rates and the fact that polio has been eradicated in many parts of the world. As a result, demand for polio vaccines has decreased significantly. While there is still some need for vaccine distribution in certain areas, the focus has shifted to maintaining immunity levels rather than new vaccinations. Moreover, funding for research and development in this area has declined as a result of polio`s elimination in Australia.
Poliomyelitis remains a critical health issue in some regions of the world, though Australia has largely eliminated the disease. The market in Australia for poliomyelitis-related products, such as vaccines and treatment options, continues to be an essential part of the healthcare system. Investment opportunities exist in the development and distribution of new vaccines and treatments, as well as in public health initiatives aimed at keeping the disease eradicated. With the global push for the eradication of polio, investing in vaccine research and international health partnerships also offers long-term growth potential for Australian companies.
Australia`s poliomyelitis market is influenced by the nation`s strong vaccination policies, which have led to the successful eradication of the disease in the country. The National Immunisation Program (NIP) ensures that all Australian children receive vaccinations, including the poliomyelitis vaccine, as part of their routine immunization schedule. The Australian government works closely with international organizations, such as the World Health Organization (WHO), to maintain polio-free status and engage in global eradication efforts. Government policies emphasize the importance of vaccination and surveillance to prevent any re-emergence of the virus.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Poliomyelitis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Poliomyelitis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Poliomyelitis Market - Industry Life Cycle |
3.4 Australia Poliomyelitis Market - Porter's Five Forces |
3.5 Australia Poliomyelitis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Poliomyelitis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Poliomyelitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Poliomyelitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Australia Poliomyelitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Poliomyelitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Poliomyelitis Market Trends |
6 Australia Poliomyelitis Market, By Types |
6.1 Australia Poliomyelitis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Poliomyelitis Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Poliomyelitis Market Revenues & Volume, By Nonparalytic Polio, 2021- 2031F |
6.1.4 Australia Poliomyelitis Market Revenues & Volume, By Nonparalytic Polio, 2021- 2031F |
6.1.5 Australia Poliomyelitis Market Revenues & Volume, By Post-Polio Syndrome, 2021- 2031F |
6.2 Australia Poliomyelitis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Poliomyelitis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Australia Poliomyelitis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 Australia Poliomyelitis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 Australia Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Poliomyelitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Poliomyelitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Poliomyelitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Australia Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Poliomyelitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Australia Poliomyelitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Poliomyelitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Australia Poliomyelitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Australia Poliomyelitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Poliomyelitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Poliomyelitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia Poliomyelitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Australia Poliomyelitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Poliomyelitis Market Import-Export Trade Statistics |
7.1 Australia Poliomyelitis Market Export to Major Countries |
7.2 Australia Poliomyelitis Market Imports from Major Countries |
8 Australia Poliomyelitis Market Key Performance Indicators |
9 Australia Poliomyelitis Market - Opportunity Assessment |
9.1 Australia Poliomyelitis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Poliomyelitis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Poliomyelitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Poliomyelitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Australia Poliomyelitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Poliomyelitis Market - Competitive Landscape |
10.1 Australia Poliomyelitis Market Revenue Share, By Companies, 2024 |
10.2 Australia Poliomyelitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |